Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion description "[The mRNA level for cannabinoid receptor type 2 (CB2) was significantly increased in AD-PBMCs as compared to healthy subjects (mean���SE of arbitrary units: 0.34���0.03 vs. 0.23���0.02 in autistic children and healthy subjects, respectively), whereas CB1 and fatty acid amide hydrolase mRNA levels were unchanged.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion evidence source_evidence_literature NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion SIO_000772 23585028 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion wasDerivedFrom befree-2016 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion wasGeneratedBy ECO_0000203 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.